Tuesday, October 21, 2025

 

Exercise counteracts junk food's depression-like effects through gut-brain metabolic signaling



Researchers reveal how voluntary running mitigates cafeteria diet-induced behavioral changes via hormonal and microbial pathways



Genomic Press

The metabolic tug-of-war: Exercise versus ultra-processed diet. 

image: 

The metabolic tug-of-war: Exercise versus ultra-processed diet. Voluntary exercise exerts an antidepressant-like behavioral effect and attenuates metabolic dysregulation in rats fed a cafeteria diet. However, diet quality still significantly influences the neuroplasticity response, highlighting the complex interplay between movement and nutrition in brain health.

view more 

Credit: Julio Licinio





CORK, IRELAND, 21 October 2025 -- Researchers led by Professor Yvonne Nolan at University College Cork have identified specific metabolic pathways through which exercise counteracts the negative behavioral effects of consuming a Western-style cafeteria diet. Published today in the peer-reviewed journal Brain Medicine, this research demonstrates that voluntary running exercise can mitigate depression-like behaviors induced by high-fat, high-sugar diets associated with both circulating hormones and gut-derived metabolites. The findings provide crucial insights into how lifestyle interventions might be optimized to support mental health in an era of widespread ultra-processed food consumption.

The research team exposed adult male rats to either standard chow or a rotating cafeteria diet consisting of various high-fat and high-sugar foods for seven and a half weeks, with half of each dietary group having access to running wheels. This experimental design allowed researchers to isolate the independent and combined effects of diet quality and physical activity on brain function and behavior.

Novel Mechanisms Linking Exercise to Mood Regulation

The study revealed that voluntary wheel running exerted an antidepressant-like behavioral effect in the context of poor diet quality, suggesting that physical activity may be beneficial for individuals consuming Western-style diets.

Professor Nolan and colleagues employed untargeted metabolomics to analyze caecal contents, revealing that the cafeteria diet dramatically altered the gut metabolome, affecting 100 out of 175 measured metabolites in sedentary animals. Exercise showed more selective effects, modulating only a subset of these changes. Three metabolites previously linked to mood regulation stood out for their response pattern: anserine, indole-3-carboxylate, and deoxyinosine were all decreased by the cafeteria diet but partially restored by exercise.

The research utilized comprehensive behavioral testing batteries to assess multiple domains of brain function. While the cafeteria diet alone did not significantly impair spatial learning or recognition memory in these adult rats, exercise produced modest improvements in spatial navigation. The team also examined anxiety-like behaviors, finding subtle anxiolytic effects of exercise independent of dietary composition.

Hormonal Pathways Mediate Diet-Exercise Interactions

Plasma hormone analysis revealed striking metabolic changes that paralleled the behavioral findings. The cafeteria diet substantially elevated insulin and leptin concentrations in sedentary animals, changes that were significantly attenuated by exercise. Dr. Minke Nota, first author of the study, notes that these hormonal normalizations likely contributed to the protective effects of exercise against diet-induced behavioral changes.

The research also uncovered complex interactions between diet and exercise on other metabolic hormones. Exercise increased circulating glucagon-like peptide 1 (GLP-1) levels in standard chow-fed animals, but this effect was blunted by the cafeteria diet. Conversely, exercise elevated peptide YY (PYY) levels specifically in cafeteria diet-fed rats, suggesting compensatory mechanisms that may help maintain metabolic homeostasis under dietary challenge.

Fibroblast growth factor 21 (FGF-21) showed robust increases in response to the cafeteria diet regardless of exercise status, while glucagon levels decreased with the dietary intervention. These multifaceted hormonal changes highlight the complex endocrine responses to lifestyle factors and their potential roles in mediating effects on brain function.

Implications for Understanding Diet-Brain Relationships

Perhaps most intriguingly, the study found that the cafeteria diet prevented the typical exercise-induced increase in adult hippocampal neurogenesis (formation of new neurons), as measured by doublecortin-positive cells in the dentate gyrus. In standard chow-fed animals, exercise robustly increased neurogenesis throughout the hippocampus, a brain region involved in emotion and memory. This finding suggests that diet quality may fundamentally alter the brain's capacity to benefit from physical activity at the cellular level.

The research team conducted correlation analyses to identify relationships between specific metabolites and behavioral outcomes. Several caecal metabolites including aminoadipic acid and 5-hydroxyindole-3-acetic acid showed negative associations with cognitive performance. These correlations were independent of experimental condition, suggesting fundamental relationships between gut metabolite profiles and brain function.

An accompanying editorial by Professor Julio Licinio and colleagues emphasizes the clinical relevance of these findings, noting that "exercise has an antidepressant-like effect in the wrong dietary context, which is good news for those who have trouble changing their diet." The editorial highlights how this research provides a biological framework for understanding why exercise remains beneficial even when dietary improvements prove challenging to implement.

Future Directions and Clinical Translation

The study raises important questions about optimal sequencing of lifestyle interventions. The findings suggest that while exercise can provide mood benefits regardless of diet quality, achieving full neuroplastic benefits may require attention to nutritional status. This has implications for designing interventions that maximize both feasibility and biological impact.

Several limitations warrant consideration. The study was conducted exclusively in male rats, and sex differences in metabolic and neurogenic responses to diet and exercise are well-documented. Additionally, the seven-week intervention period may not capture longer-term adaptations that could emerge with chronic exposure. Future studies incorporating female animals, longer intervention periods, and dose-response designs will help refine understanding of these complex interactions.

The research also opens new avenues for investigating specific metabolites as potential therapeutic targets. The protective effects of exercise on anserine, indole-3-carboxylate, and deoxyinosine levels suggest these compounds may serve as biomarkers or even therapeutic agents for mood disorders. The strong correlations between specific gut metabolites and behavioral measures support growing interest in the microbiota-gut-brain axis as a target for mental health interventions.

This peer-reviewed research represents a significant advance in understanding the biological mechanisms linking diet, exercise, and mental health, offering new insights into how lifestyle factors interact at molecular and cellular levels to influence brain function. The findings challenge existing paradigms about the relationship between metabolic and mental health by demonstrating that exercise can provide antidepressant-like effects even in the context of poor dietary choices. By employing innovative metabolomic approaches combined with comprehensive behavioral and neurobiological assessments, the research team has generated data that not only advances fundamental knowledge but also suggests practical applications for addressing the mental health challenges associated with modern dietary patterns. The reproducibility and validation of these findings through the peer-review process ensures their reliability and positions them as a foundation for future investigations. This work exemplifies how cutting-edge research can bridge the gap between basic science and translational applications, potentially impacting individuals struggling with mood disorders in the coming years.

The Research Article in Brain Medicine titled "Exercise mitigates the effects of a cafeteria diet on antidepressant-like behaviour associated with plasma and microbial metabolites in adult male rats," is freely available via Open Access on 21 October 2025 in Brain Medicine at the following hyperlink: https://doi.org/10.61373/bm025a.0116.

The accompanying Editorial in Brain Medicine titled "Exercise as metabolic medicine: Movement counters diet-induced behavioral despair via gut-brain signaling," is also freely available via Open Access on 21 October 2025 in Brain Medicine at the following hyperlink: https://doi.org/10.61373/bm025d.0122.

About Brain Medicine: Brain Medicine (ISSN: 2997-2639, online and 2997-2647, print) is a peer-reviewed medical research journal published by Genomic Press, New York. Brain Medicine is a new home for the cross-disciplinary pathway from innovation in fundamental neuroscience to translational initiatives in brain medicine. The journal's scope includes the underlying science, causes, outcomes, treatments, and societal impact of brain disorders, across all clinical disciplines and their interface.

Visit the Genomic Press Virtual Library: https://issues.genomicpress.com/bookcase/gtvov/

Our full website is at: https://genomicpress.kglmeridian.com/


Exercise mitigates the effects of a cafeteria diet on antidepressant-like behavior associated with plasma and microbial metabolites in adult male rats

Credit

Yvonne Nolan

Exercise as metabolic medicine: Movement counters diet-induced behavioral despair via gut-brain signaling

Credit

Julio Licinio

Psychedelics reshape time perception offering new therapeutic pathways



Perspective article examines how temporal distortions unlock consciousness insights





Genomic Press

Neurobiological mechanisms of psychedelic-induced time perception alterations. 

image: 

Neurobiological mechanisms of psychedelic-induced time perception alterations.

view more 

Credit: Xiaohui Wang



CHANGCHUN, CHINA, 21 October 2025 -- A perspective article published today in Psychedelics by Prof. Xiaohui Wang and colleagues examine how psychedelic substances profoundly reshape our perception of time, offering unprecedented insights into consciousness and potential therapeutic applications. The analysis synthesizes existing research on temporal distortions induced by substances including psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT), revealing how these compounds provide unique windows into brain function and mental health treatment.

Time perception forms the foundation of human consciousness, yet psychedelics can dramatically alter this fundamental aspect of experience. Users frequently report seconds feeling like hours, hours compressed into minutes, or complete dissolution of temporal boundaries. These phenomena extend beyond subjective curiosity, offering researchers crucial data about how the brain constructs our sense of time and self.

Neural Networks Under Psychedelic Influence

The perspective article identifies key neurobiological mechanisms underlying these temporal distortions. Central to these changes is the default mode network (DMN), a brain system associated with self-referential thinking and continuous time perception. Psychedelics suppress DMN activity, correlating strongly with reports of time dissolution and loss of linear temporal experience. This suppression appears particularly relevant for therapeutic applications, as excessive DMN activity characterizes several psychiatric conditions.

Prof. Wang highlights how psychedelics modulate multiple brain regions simultaneously. The basal ganglia, typically responsible for interval timing on millisecond scales, shows altered function under psychedelic influence. The prefrontal cortex, which encodes longer time spans and integrates temporal information for planning, exhibits changed connectivity patterns. The cerebellum, crucial for precise timing of motor events, and the insula, which links body states with time perception, both demonstrate modified activity patterns.

Neurotransmitter systems play pivotal roles in these alterations. Serotonin receptors, particularly through 5-HT2A receptor activation, emerges as the primary mediator of psychedelic temporal effects. This receptor activation enhances cortical excitability and increases sensory input gain, potentially explaining why time appears to dilate when processing increases. The analysis also notes dopamine involvement in shorter interval timing disruptions and glutamate participation through NMDA receptor-mediated processes.

From Dilation to Timelessness

The perspective describes three main categories of temporal distortion. Time dilation, where brief periods feel extended, may result from enhanced sensory processing as psychedelics elevate neural oscillations in brain regions specialized for sensory and emotional input. Conversely, time compression, where hours pass like minutes, could relate to intense attentional focus or ego dissolution loosening typical perceptual holds on temporal flow.

Perhaps most intriguingly, many users report complete timelessness, experiencing past, present, and future as unified or irrelevant. These experiences often occur within profound mystical states and correlate with DMN suppression. Such states raise fundamental questions about whether linear time represents a cognitive construction rather than an absolute reality.

The authors note important substance-specific differences. Psilocybin tends to produce experiences of timelessness, while LSD more frequently induces profound time dilation. These distinctions suggest different pharmacological profiles produce varying temporal effects, highlighting the complexity of neural substrates mediating temporal experience.

Therapeutic Implications Emerge

The perspective article emphasizes therapeutic potential in conditions where temporal perception dysfunction plays a central role. Post-traumatic stress disorder (PTSD), depression, and anxiety all involve altered relationships with time. PTSD patients often feel trapped in past trauma, depression frequently involves feeling stuck in negative temporal loops, and anxiety centers on future-focused temporal distress.

Evidence from psychedelic-assisted psychotherapy trials suggests these substances enable individuals to revisit traumatic memories from detached, nonlinear perspectives. This temporal decoupling allows processing of past experiences with reduced emotional intensity, supporting meaning-making and integration. Patients describe these temporal shifts as significant factors in symptom improvement.

Prof. Wang notes that psychedelics may effectively rewire neural circuits involved in both time processing and emotion regulation. By disrupting maladaptive temporal patterns, these substances could facilitate development of healthier time perceptions. This mechanism appears particularly relevant for treatment-resistant conditions where conventional therapies fail to shift entrenched temporal-emotional patterns.

Rigorous Frameworks Required

While acknowledging therapeutic promise, the authors emphasize necessary ethical considerations and safety protocols. They stress that administration should occur only in controlled settings with professional oversight. Robust informed consent processes must ensure patients understand potential for profound consciousness alterations, including potentially distressing temporal distortions.

The perspective calls for systematic evaluation through longitudinal studies tracking objective time perception measures and neural activity in patients undergoing psychedelic-assisted therapy. Such research could establish whether temporal perception changes mediate therapeutic outcomes or represent parallel phenomena.

Regulatory challenges persist, as many psychedelics remain Schedule I substances, limiting research opportunities. The authors advocate for clear safety monitoring guidelines and defined regulatory pathways enabling responsible therapeutic integration while preventing misuse.

Future Research Directions

The analysis identifies critical gaps requiring investigation. How do different psychedelic compounds produce distinct temporal effects? What role does neural synchrony, particularly theta and gamma oscillations, play in maintaining normal time perception? Can specific temporal distortion profiles predict therapeutic outcomes for different conditions?

The authors propose that understanding psychedelic effects on time perception could revolutionize approaches to psychiatric disorders. Rather than viewing these conditions solely through emotional or cognitive lenses, incorporating temporal perception as a treatment target opens novel therapeutic avenues.

This perspective article represents a critical synthesis of the current state of knowledge in psychedelic temporal effects, providing researchers, clinicians, and policymakers with a comprehensive framework for understanding these phenomena. By systematically analyzing and integrating findings from across the literature, the authors offer both a historical perspective on how the field has evolved and a roadmap for future investigations. Such comprehensive reviews are essential for identifying patterns that may not be apparent in individual studies, resolving apparent contradictions in the literature, and highlighting the most promising avenues for advancing the field. The synthesis presented here serves as a valuable resource for both newcomers seeking to understand the field and experienced researchers looking to contextualize their work within the broader scientific landscape.

The Perspective in Psychedelics titled "Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy," is freely available via Open Access on 21 October 2025 in Psychedelics at the following hyperlink: https://doi.org/10.61373/pp025p.0041.

About Psychedelics: Psychedelics: The Journal of Psychedelic and Psychoactive Drug Research (ISSN: 2997-2671, online and 2997-268X, print) is a peer reviewed medical research journal published by Genomic Press, New York. Psychedelics is dedicated to advancing knowledge across the full spectrum of consciousness altering substances, from classical psychedelics to stimulants, cannabinoids, entactogens, dissociatives, plant derived compounds, and novel compounds including drug discovery approaches. Our multidisciplinary approach encompasses molecular mechanisms, therapeutic applications, neuroscientific discoveries, and sociocultural analyses. We welcome diverse methodologies and perspectives from fundamental pharmacology and clinical studies to psychological investigations and societal-historical contexts that enhance our understanding of how these substances interact with human biology, psychology, and society.

Visit the Genomic Press Virtual Library: https://issues.genomicpress.com/bookcase/gtvov/

Our full website is at: https://genomicpress.kglmeridian.com/


Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy

Credit

Xiaohui Wang

 The Doors of Perception ALDOUS HUXLEY